nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—S1PR1—blood vessel—stomach cancer	0.0174	0.0551	CbGeAlD
Fingolimod—S1PR4—hematopoietic system—stomach cancer	0.0151	0.0476	CbGeAlD
Fingolimod—S1PR5—hematopoietic system—stomach cancer	0.0127	0.04	CbGeAlD
Fingolimod—CYP4F2—hematopoietic system—stomach cancer	0.0119	0.0375	CbGeAlD
Fingolimod—S1PR4—lymphoid tissue—stomach cancer	0.0106	0.0335	CbGeAlD
Fingolimod—S1PR3—hematopoietic system—stomach cancer	0.0105	0.0333	CbGeAlD
Fingolimod—S1PR4—bone marrow—stomach cancer	0.00966	0.0305	CbGeAlD
Fingolimod—S1PR1—hematopoietic system—stomach cancer	0.00928	0.0293	CbGeAlD
Fingolimod—S1PR3—smooth muscle tissue—stomach cancer	0.00927	0.0293	CbGeAlD
Fingolimod—SPHK1—hematopoietic system—stomach cancer	0.00918	0.029	CbGeAlD
Fingolimod—S1PR5—lymphoid tissue—stomach cancer	0.00892	0.0282	CbGeAlD
Fingolimod—S1PR4—endocrine gland—stomach cancer	0.00866	0.0274	CbGeAlD
Fingolimod—S1PR3—pancreas—stomach cancer	0.00857	0.0271	CbGeAlD
Fingolimod—S1PR1—epithelium—stomach cancer	0.00848	0.0268	CbGeAlD
Fingolimod—CYP4F2—digestive system—stomach cancer	0.00825	0.0261	CbGeAlD
Fingolimod—S1PR1—smooth muscle tissue—stomach cancer	0.00817	0.0258	CbGeAlD
Fingolimod—SPHK1—smooth muscle tissue—stomach cancer	0.00809	0.0255	CbGeAlD
Fingolimod—CYP4F2—bone marrow—stomach cancer	0.00761	0.024	CbGeAlD
Fingolimod—S1PR3—lymphoid tissue—stomach cancer	0.00741	0.0234	CbGeAlD
Fingolimod—S1PR5—endocrine gland—stomach cancer	0.00728	0.023	CbGeAlD
Fingolimod—CYP4F12—pancreas—stomach cancer	0.00718	0.0227	CbGeAlD
Fingolimod—CYP4F2—endocrine gland—stomach cancer	0.00682	0.0215	CbGeAlD
Fingolimod—S1PR5—liver—stomach cancer	0.00656	0.0207	CbGeAlD
Fingolimod—S1PR1—lymphoid tissue—stomach cancer	0.00653	0.0206	CbGeAlD
Fingolimod—CYP4F2—liver—stomach cancer	0.00615	0.0194	CbGeAlD
Fingolimod—CYP4F12—digestive system—stomach cancer	0.00613	0.0194	CbGeAlD
Fingolimod—S1PR3—endocrine gland—stomach cancer	0.00605	0.0191	CbGeAlD
Fingolimod—S1PR4—lymph node—stomach cancer	0.00599	0.0189	CbGeAlD
Fingolimod—CYP4F12—bone marrow—stomach cancer	0.00565	0.0179	CbGeAlD
Fingolimod—S1PR3—liver—stomach cancer	0.00545	0.0172	CbGeAlD
Fingolimod—S1PR1—endocrine gland—stomach cancer	0.00533	0.0168	CbGeAlD
Fingolimod—SPHK1—endocrine gland—stomach cancer	0.00528	0.0167	CbGeAlD
Fingolimod—CYP4F12—endocrine gland—stomach cancer	0.00507	0.016	CbGeAlD
Fingolimod—S1PR5—lymph node—stomach cancer	0.00503	0.0159	CbGeAlD
Fingolimod—S1PR1—liver—stomach cancer	0.00481	0.0152	CbGeAlD
Fingolimod—CYP4F12—liver—stomach cancer	0.00457	0.0144	CbGeAlD
Fingolimod—S1PR3—lymph node—stomach cancer	0.00418	0.0132	CbGeAlD
Fingolimod—S1PR1—lymph node—stomach cancer	0.00369	0.0116	CbGeAlD
Fingolimod—SPHK1—lymph node—stomach cancer	0.00365	0.0115	CbGeAlD
Fingolimod—CYP4F12—lymph node—stomach cancer	0.0035	0.0111	CbGeAlD
Fingolimod—CYP2E1—hematopoietic system—stomach cancer	0.00149	0.0047	CbGeAlD
Fingolimod—Fatigue—Mitomycin—stomach cancer	0.00137	0.00596	CcSEcCtD
Fingolimod—Cardiac arrest—Irinotecan—stomach cancer	0.00133	0.00581	CcSEcCtD
Fingolimod—Herpes zoster—Methotrexate—stomach cancer	0.00128	0.00557	CcSEcCtD
Fingolimod—Cardiac arrest—Fluorouracil—stomach cancer	0.00127	0.00556	CcSEcCtD
Fingolimod—Headache—Floxuridine—stomach cancer	0.00126	0.00552	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Irinotecan—stomach cancer	0.00126	0.0055	CcSEcCtD
Fingolimod—CYP3A4—hematopoietic system—stomach cancer	0.0012	0.00378	CbGeAlD
Fingolimod—Herpes zoster—Epirubicin—stomach cancer	0.00119	0.00521	CcSEcCtD
Fingolimod—CYP2D6—hematopoietic system—stomach cancer	0.00118	0.00372	CbGeAlD
Fingolimod—Asthenia—Mitomycin—stomach cancer	0.00114	0.00496	CcSEcCtD
Fingolimod—Herpes zoster—Doxorubicin—stomach cancer	0.0011	0.00482	CcSEcCtD
Fingolimod—Weight decreased—Irinotecan—stomach cancer	0.00109	0.00478	CcSEcCtD
Fingolimod—Pneumonia—Irinotecan—stomach cancer	0.00108	0.00473	CcSEcCtD
Fingolimod—Diarrhoea—Mitomycin—stomach cancer	0.00108	0.00473	CcSEcCtD
Fingolimod—Liver injury—Epirubicin—stomach cancer	0.00107	0.00466	CcSEcCtD
Fingolimod—Gastroenteritis—Capecitabine—stomach cancer	0.00106	0.00461	CcSEcCtD
Fingolimod—Dizziness—Mitomycin—stomach cancer	0.00105	0.00457	CcSEcCtD
Fingolimod—CYP2E1—lymphoid tissue—stomach cancer	0.00105	0.00331	CbGeAlD
Fingolimod—Pneumonia—Fluorouracil—stomach cancer	0.00104	0.00453	CcSEcCtD
Fingolimod—Eye pain—Capecitabine—stomach cancer	0.00104	0.00453	CcSEcCtD
Fingolimod—CYP2E1—digestive system—stomach cancer	0.00103	0.00327	CbGeAlD
Fingolimod—Infestation—Fluorouracil—stomach cancer	0.00103	0.00451	CcSEcCtD
Fingolimod—Infestation NOS—Fluorouracil—stomach cancer	0.00103	0.00451	CcSEcCtD
Fingolimod—Hepatic enzyme increased—Methotrexate—stomach cancer	0.00102	0.00443	CcSEcCtD
Fingolimod—Headache—Mitomycin—stomach cancer	0.000992	0.00433	CcSEcCtD
Fingolimod—Liver injury—Doxorubicin—stomach cancer	0.000989	0.00431	CcSEcCtD
Fingolimod—Bradycardia—Irinotecan—stomach cancer	0.000986	0.0043	CcSEcCtD
Fingolimod—Sinusitis—Fluorouracil—stomach cancer	0.000969	0.00423	CcSEcCtD
Fingolimod—Cerebrovascular accident—Capecitabine—stomach cancer	0.000956	0.00417	CcSEcCtD
Fingolimod—Migraine—Docetaxel—stomach cancer	0.000952	0.00416	CcSEcCtD
Fingolimod—Connective tissue disorder—Irinotecan—stomach cancer	0.000952	0.00415	CcSEcCtD
Fingolimod—Atrioventricular block—Epirubicin—stomach cancer	0.000927	0.00404	CcSEcCtD
Fingolimod—Migraine—Capecitabine—stomach cancer	0.000922	0.00402	CcSEcCtD
Fingolimod—Cardiac disorder—Irinotecan—stomach cancer	0.000899	0.00392	CcSEcCtD
Fingolimod—Liver function test abnormal—Docetaxel—stomach cancer	0.000893	0.0039	CcSEcCtD
Fingolimod—Cardiac arrest—Capecitabine—stomach cancer	0.000891	0.00389	CcSEcCtD
Fingolimod—Angiopathy—Irinotecan—stomach cancer	0.000879	0.00383	CcSEcCtD
Fingolimod—Mediastinal disorder—Irinotecan—stomach cancer	0.000873	0.00381	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Docetaxel—stomach cancer	0.000871	0.0038	CcSEcCtD
Fingolimod—Liver function test abnormal—Capecitabine—stomach cancer	0.000865	0.00377	CcSEcCtD
Fingolimod—Atrioventricular block—Doxorubicin—stomach cancer	0.000858	0.00374	CcSEcCtD
Fingolimod—Alopecia—Irinotecan—stomach cancer	0.000856	0.00373	CcSEcCtD
Fingolimod—CYP2E1—endocrine gland—stomach cancer	0.000855	0.0027	CbGeAlD
Fingolimod—Alanine aminotransferase increased—Docetaxel—stomach cancer	0.000853	0.00372	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Capecitabine—stomach cancer	0.000844	0.00368	CcSEcCtD
Fingolimod—CYP3A4—digestive system—stomach cancer	0.000832	0.00263	CbGeAlD
Fingolimod—Alanine aminotransferase increased—Capecitabine—stomach cancer	0.000826	0.00361	CcSEcCtD
Fingolimod—Alopecia—Fluorouracil—stomach cancer	0.00082	0.00358	CcSEcCtD
Fingolimod—CYP2D6—digestive system—stomach cancer	0.000819	0.00259	CbGeAlD
Fingolimod—Back pain—Irinotecan—stomach cancer	0.000815	0.00356	CcSEcCtD
Fingolimod—Influenza—Capecitabine—stomach cancer	0.00081	0.00353	CcSEcCtD
Fingolimod—Bronchitis—Capecitabine—stomach cancer	0.000779	0.0034	CcSEcCtD
Fingolimod—CYP2E1—liver—stomach cancer	0.000771	0.00243	CbGeAlD
Fingolimod—Vision blurred—Fluorouracil—stomach cancer	0.000761	0.00332	CcSEcCtD
Fingolimod—Weight decreased—Docetaxel—stomach cancer	0.000757	0.0033	CcSEcCtD
Fingolimod—Leukopenia—Irinotecan—stomach cancer	0.000755	0.00329	CcSEcCtD
Fingolimod—Pneumonia—Docetaxel—stomach cancer	0.00075	0.00327	CcSEcCtD
Fingolimod—Infestation NOS—Docetaxel—stomach cancer	0.000746	0.00325	CcSEcCtD
Fingolimod—Infestation—Docetaxel—stomach cancer	0.000746	0.00325	CcSEcCtD
Fingolimod—Cough—Irinotecan—stomach cancer	0.000736	0.00321	CcSEcCtD
Fingolimod—Weight decreased—Capecitabine—stomach cancer	0.000733	0.0032	CcSEcCtD
Fingolimod—Hypertension—Irinotecan—stomach cancer	0.000728	0.00318	CcSEcCtD
Fingolimod—Eczema—Epirubicin—stomach cancer	0.000726	0.00317	CcSEcCtD
Fingolimod—Pneumonia—Capecitabine—stomach cancer	0.000726	0.00317	CcSEcCtD
Fingolimod—Eye pain—Epirubicin—stomach cancer	0.000723	0.00315	CcSEcCtD
Fingolimod—Leukopenia—Fluorouracil—stomach cancer	0.000723	0.00315	CcSEcCtD
Fingolimod—Infestation NOS—Capecitabine—stomach cancer	0.000722	0.00315	CcSEcCtD
Fingolimod—Infestation—Capecitabine—stomach cancer	0.000722	0.00315	CcSEcCtD
Fingolimod—Depression—Capecitabine—stomach cancer	0.00072	0.00314	CcSEcCtD
Fingolimod—Cerebrovascular accident—Methotrexate—stomach cancer	0.000712	0.00311	CcSEcCtD
Fingolimod—CYP3A4—endocrine gland—stomach cancer	0.000688	0.00217	CbGeAlD
Fingolimod—Infection—Irinotecan—stomach cancer	0.000683	0.00298	CcSEcCtD
Fingolimod—CYP2D6—endocrine gland—stomach cancer	0.000677	0.00214	CbGeAlD
Fingolimod—Nervous system disorder—Irinotecan—stomach cancer	0.000675	0.00294	CcSEcCtD
Fingolimod—Eczema—Doxorubicin—stomach cancer	0.000672	0.00293	CcSEcCtD
Fingolimod—Eye pain—Doxorubicin—stomach cancer	0.000669	0.00292	CcSEcCtD
Fingolimod—Cerebrovascular accident—Epirubicin—stomach cancer	0.000666	0.00291	CcSEcCtD
Fingolimod—Bradycardia—Capecitabine—stomach cancer	0.00066	0.00288	CcSEcCtD
Fingolimod—Connective tissue disorder—Docetaxel—stomach cancer	0.000658	0.00287	CcSEcCtD
Fingolimod—Infection—Fluorouracil—stomach cancer	0.000655	0.00286	CcSEcCtD
Fingolimod—Nervous system disorder—Fluorouracil—stomach cancer	0.000646	0.00282	CcSEcCtD
Fingolimod—Liver function test abnormal—Methotrexate—stomach cancer	0.000644	0.00281	CcSEcCtD
Fingolimod—Hypotension—Irinotecan—stomach cancer	0.000643	0.00281	CcSEcCtD
Fingolimod—Migraine—Epirubicin—stomach cancer	0.000642	0.0028	CcSEcCtD
Fingolimod—Connective tissue disorder—Capecitabine—stomach cancer	0.000637	0.00278	CcSEcCtD
Fingolimod—Eye disorder—Docetaxel—stomach cancer	0.000626	0.00273	CcSEcCtD
Fingolimod—Cardiac disorder—Docetaxel—stomach cancer	0.000621	0.00271	CcSEcCtD
Fingolimod—Cardiac arrest—Epirubicin—stomach cancer	0.000621	0.00271	CcSEcCtD
Fingolimod—CYP3A4—liver—stomach cancer	0.00062	0.00196	CbGeAlD
Fingolimod—Paraesthesia—Irinotecan—stomach cancer	0.000618	0.0027	CcSEcCtD
Fingolimod—Cerebrovascular accident—Doxorubicin—stomach cancer	0.000616	0.00269	CcSEcCtD
Fingolimod—Hypotension—Fluorouracil—stomach cancer	0.000616	0.00269	CcSEcCtD
Fingolimod—Dyspnoea—Irinotecan—stomach cancer	0.000613	0.00268	CcSEcCtD
Fingolimod—CYP2D6—liver—stomach cancer	0.00061	0.00193	CbGeAlD
Fingolimod—Angiopathy—Docetaxel—stomach cancer	0.000607	0.00265	CcSEcCtD
Fingolimod—Eye disorder—Capecitabine—stomach cancer	0.000606	0.00264	CcSEcCtD
Fingolimod—Mediastinal disorder—Docetaxel—stomach cancer	0.000603	0.00263	CcSEcCtD
Fingolimod—Liver function test abnormal—Epirubicin—stomach cancer	0.000603	0.00263	CcSEcCtD
Fingolimod—Cardiac disorder—Capecitabine—stomach cancer	0.000601	0.00262	CcSEcCtD
Fingolimod—Migraine—Doxorubicin—stomach cancer	0.000594	0.00259	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000594	0.00259	CcSEcCtD
Fingolimod—Fatigue—Irinotecan—stomach cancer	0.000593	0.00259	CcSEcCtD
Fingolimod—Paraesthesia—Fluorouracil—stomach cancer	0.000592	0.00258	CcSEcCtD
Fingolimod—Alopecia—Docetaxel—stomach cancer	0.000591	0.00258	CcSEcCtD
Fingolimod—Angiopathy—Capecitabine—stomach cancer	0.000588	0.00257	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Epirubicin—stomach cancer	0.000588	0.00256	CcSEcCtD
Fingolimod—Dyspnoea—Fluorouracil—stomach cancer	0.000587	0.00256	CcSEcCtD
Fingolimod—Mental disorder—Docetaxel—stomach cancer	0.000586	0.00256	CcSEcCtD
Fingolimod—Mediastinal disorder—Capecitabine—stomach cancer	0.000584	0.00255	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Epirubicin—stomach cancer	0.000576	0.00251	CcSEcCtD
Fingolimod—Cardiac arrest—Doxorubicin—stomach cancer	0.000574	0.00251	CcSEcCtD
Fingolimod—Alopecia—Capecitabine—stomach cancer	0.000573	0.0025	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000569	0.00248	CcSEcCtD
Fingolimod—Mental disorder—Capecitabine—stomach cancer	0.000568	0.00248	CcSEcCtD
Fingolimod—Influenza—Epirubicin—stomach cancer	0.000564	0.00246	CcSEcCtD
Fingolimod—Back pain—Docetaxel—stomach cancer	0.000564	0.00246	CcSEcCtD
Fingolimod—Liver function test abnormal—Doxorubicin—stomach cancer	0.000557	0.00243	CcSEcCtD
Fingolimod—Back pain—Capecitabine—stomach cancer	0.000546	0.00238	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Doxorubicin—stomach cancer	0.000544	0.00237	CcSEcCtD
Fingolimod—Bronchitis—Epirubicin—stomach cancer	0.000542	0.00237	CcSEcCtD
Fingolimod—Pneumonia—Methotrexate—stomach cancer	0.000541	0.00236	CcSEcCtD
Fingolimod—Infestation NOS—Methotrexate—stomach cancer	0.000537	0.00235	CcSEcCtD
Fingolimod—Infestation—Methotrexate—stomach cancer	0.000537	0.00235	CcSEcCtD
Fingolimod—Depression—Methotrexate—stomach cancer	0.000536	0.00234	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.000533	0.00232	CcSEcCtD
Fingolimod—Vision blurred—Capecitabine—stomach cancer	0.000532	0.00232	CcSEcCtD
Fingolimod—Influenza—Doxorubicin—stomach cancer	0.000522	0.00228	CcSEcCtD
Fingolimod—Leukopenia—Docetaxel—stomach cancer	0.000522	0.00228	CcSEcCtD
Fingolimod—Palpitations—Docetaxel—stomach cancer	0.000515	0.00225	CcSEcCtD
Fingolimod—Weight decreased—Epirubicin—stomach cancer	0.00051	0.00223	CcSEcCtD
Fingolimod—Cough—Docetaxel—stomach cancer	0.000508	0.00222	CcSEcCtD
Fingolimod—Pneumonia—Epirubicin—stomach cancer	0.000506	0.00221	CcSEcCtD
Fingolimod—Leukopenia—Capecitabine—stomach cancer	0.000505	0.0022	CcSEcCtD
Fingolimod—Hypertension—Docetaxel—stomach cancer	0.000503	0.0022	CcSEcCtD
Fingolimod—Infestation NOS—Epirubicin—stomach cancer	0.000503	0.00219	CcSEcCtD
Fingolimod—Infestation—Epirubicin—stomach cancer	0.000503	0.00219	CcSEcCtD
Fingolimod—Bronchitis—Doxorubicin—stomach cancer	0.000502	0.00219	CcSEcCtD
Fingolimod—Palpitations—Capecitabine—stomach cancer	0.000499	0.00218	CcSEcCtD
Fingolimod—Asthenia—Irinotecan—stomach cancer	0.000494	0.00215	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000493	0.00215	CcSEcCtD
Fingolimod—Cough—Capecitabine—stomach cancer	0.000492	0.00215	CcSEcCtD
Fingolimod—Hypertension—Capecitabine—stomach cancer	0.000487	0.00213	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000477	0.00208	CcSEcCtD
Fingolimod—Infection—Docetaxel—stomach cancer	0.000472	0.00206	CcSEcCtD
Fingolimod—Weight decreased—Doxorubicin—stomach cancer	0.000472	0.00206	CcSEcCtD
Fingolimod—Sinusitis—Epirubicin—stomach cancer	0.000472	0.00206	CcSEcCtD
Fingolimod—Diarrhoea—Irinotecan—stomach cancer	0.000471	0.00205	CcSEcCtD
Fingolimod—Pneumonia—Doxorubicin—stomach cancer	0.000468	0.00204	CcSEcCtD
Fingolimod—Nervous system disorder—Docetaxel—stomach cancer	0.000466	0.00204	CcSEcCtD
Fingolimod—Pruritus—Fluorouracil—stomach cancer	0.000466	0.00203	CcSEcCtD
Fingolimod—Infestation NOS—Doxorubicin—stomach cancer	0.000465	0.00203	CcSEcCtD
Fingolimod—Infestation—Doxorubicin—stomach cancer	0.000465	0.00203	CcSEcCtD
Fingolimod—Skin disorder—Docetaxel—stomach cancer	0.000462	0.00202	CcSEcCtD
Fingolimod—Bradycardia—Epirubicin—stomach cancer	0.00046	0.00201	CcSEcCtD
Fingolimod—Infection—Capecitabine—stomach cancer	0.000457	0.002	CcSEcCtD
Fingolimod—Dizziness—Irinotecan—stomach cancer	0.000455	0.00199	CcSEcCtD
Fingolimod—Nervous system disorder—Capecitabine—stomach cancer	0.000452	0.00197	CcSEcCtD
Fingolimod—Eye disorder—Methotrexate—stomach cancer	0.000451	0.00197	CcSEcCtD
Fingolimod—Diarrhoea—Fluorouracil—stomach cancer	0.000451	0.00197	CcSEcCtD
Fingolimod—Cardiac disorder—Methotrexate—stomach cancer	0.000448	0.00195	CcSEcCtD
Fingolimod—Skin disorder—Capecitabine—stomach cancer	0.000447	0.00195	CcSEcCtD
Fingolimod—Hypotension—Docetaxel—stomach cancer	0.000444	0.00194	CcSEcCtD
Fingolimod—Connective tissue disorder—Epirubicin—stomach cancer	0.000444	0.00194	CcSEcCtD
Fingolimod—Angiopathy—Methotrexate—stomach cancer	0.000438	0.00191	CcSEcCtD
Fingolimod—Sinusitis—Doxorubicin—stomach cancer	0.000437	0.00191	CcSEcCtD
Fingolimod—Dizziness—Fluorouracil—stomach cancer	0.000436	0.0019	CcSEcCtD
Fingolimod—Mediastinal disorder—Methotrexate—stomach cancer	0.000435	0.0019	CcSEcCtD
Fingolimod—Headache—Irinotecan—stomach cancer	0.000431	0.00188	CcSEcCtD
Fingolimod—Hypotension—Capecitabine—stomach cancer	0.00043	0.00188	CcSEcCtD
Fingolimod—Paraesthesia—Docetaxel—stomach cancer	0.000427	0.00186	CcSEcCtD
Fingolimod—Alopecia—Methotrexate—stomach cancer	0.000426	0.00186	CcSEcCtD
Fingolimod—Bradycardia—Doxorubicin—stomach cancer	0.000425	0.00186	CcSEcCtD
Fingolimod—Dyspnoea—Docetaxel—stomach cancer	0.000424	0.00185	CcSEcCtD
Fingolimod—Mental disorder—Methotrexate—stomach cancer	0.000423	0.00184	CcSEcCtD
Fingolimod—Eye disorder—Epirubicin—stomach cancer	0.000422	0.00184	CcSEcCtD
Fingolimod—Cardiac disorder—Epirubicin—stomach cancer	0.000419	0.00183	CcSEcCtD
Fingolimod—Paraesthesia—Capecitabine—stomach cancer	0.000413	0.0018	CcSEcCtD
Fingolimod—Headache—Fluorouracil—stomach cancer	0.000413	0.0018	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000411	0.00179	CcSEcCtD
Fingolimod—Connective tissue disorder—Doxorubicin—stomach cancer	0.000411	0.00179	CcSEcCtD
Fingolimod—Dyspnoea—Capecitabine—stomach cancer	0.00041	0.00179	CcSEcCtD
Fingolimod—Fatigue—Docetaxel—stomach cancer	0.00041	0.00179	CcSEcCtD
Fingolimod—Angiopathy—Epirubicin—stomach cancer	0.00041	0.00179	CcSEcCtD
Fingolimod—Mediastinal disorder—Epirubicin—stomach cancer	0.000407	0.00178	CcSEcCtD
Fingolimod—Back pain—Methotrexate—stomach cancer	0.000406	0.00177	CcSEcCtD
Fingolimod—Alopecia—Epirubicin—stomach cancer	0.000399	0.00174	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000397	0.00173	CcSEcCtD
Fingolimod—Fatigue—Capecitabine—stomach cancer	0.000397	0.00173	CcSEcCtD
Fingolimod—Vision blurred—Methotrexate—stomach cancer	0.000396	0.00173	CcSEcCtD
Fingolimod—Mental disorder—Epirubicin—stomach cancer	0.000396	0.00173	CcSEcCtD
Fingolimod—Eye disorder—Doxorubicin—stomach cancer	0.00039	0.0017	CcSEcCtD
Fingolimod—Cardiac disorder—Doxorubicin—stomach cancer	0.000388	0.00169	CcSEcCtD
Fingolimod—Back pain—Epirubicin—stomach cancer	0.00038	0.00166	CcSEcCtD
Fingolimod—Angiopathy—Doxorubicin—stomach cancer	0.000379	0.00165	CcSEcCtD
Fingolimod—Mediastinal disorder—Doxorubicin—stomach cancer	0.000376	0.00164	CcSEcCtD
Fingolimod—Leukopenia—Methotrexate—stomach cancer	0.000376	0.00164	CcSEcCtD
Fingolimod—Vision blurred—Epirubicin—stomach cancer	0.00037	0.00162	CcSEcCtD
Fingolimod—Alopecia—Doxorubicin—stomach cancer	0.000369	0.00161	CcSEcCtD
Fingolimod—Cough—Methotrexate—stomach cancer	0.000366	0.0016	CcSEcCtD
Fingolimod—Mental disorder—Doxorubicin—stomach cancer	0.000366	0.0016	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000355	0.00155	CcSEcCtD
Fingolimod—Leukopenia—Epirubicin—stomach cancer	0.000352	0.00154	CcSEcCtD
Fingolimod—Back pain—Doxorubicin—stomach cancer	0.000352	0.00154	CcSEcCtD
Fingolimod—Palpitations—Epirubicin—stomach cancer	0.000347	0.00152	CcSEcCtD
Fingolimod—Cough—Epirubicin—stomach cancer	0.000343	0.0015	CcSEcCtD
Fingolimod—Vision blurred—Doxorubicin—stomach cancer	0.000343	0.0015	CcSEcCtD
Fingolimod—Asthenia—Docetaxel—stomach cancer	0.000341	0.00149	CcSEcCtD
Fingolimod—Infection—Methotrexate—stomach cancer	0.000341	0.00149	CcSEcCtD
Fingolimod—Hypertension—Epirubicin—stomach cancer	0.000339	0.00148	CcSEcCtD
Fingolimod—Pruritus—Docetaxel—stomach cancer	0.000336	0.00147	CcSEcCtD
Fingolimod—Nervous system disorder—Methotrexate—stomach cancer	0.000336	0.00147	CcSEcCtD
Fingolimod—Skin disorder—Methotrexate—stomach cancer	0.000333	0.00145	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000332	0.00145	CcSEcCtD
Fingolimod—Asthenia—Capecitabine—stomach cancer	0.00033	0.00144	CcSEcCtD
Fingolimod—Pruritus—Capecitabine—stomach cancer	0.000326	0.00142	CcSEcCtD
Fingolimod—Leukopenia—Doxorubicin—stomach cancer	0.000326	0.00142	CcSEcCtD
Fingolimod—Diarrhoea—Docetaxel—stomach cancer	0.000325	0.00142	CcSEcCtD
Fingolimod—Palpitations—Doxorubicin—stomach cancer	0.000321	0.0014	CcSEcCtD
Fingolimod—Hypotension—Methotrexate—stomach cancer	0.00032	0.0014	CcSEcCtD
Fingolimod—Infection—Epirubicin—stomach cancer	0.000319	0.00139	CcSEcCtD
Fingolimod—Cough—Doxorubicin—stomach cancer	0.000317	0.00138	CcSEcCtD
Fingolimod—Diarrhoea—Capecitabine—stomach cancer	0.000315	0.00137	CcSEcCtD
Fingolimod—Nervous system disorder—Epirubicin—stomach cancer	0.000315	0.00137	CcSEcCtD
Fingolimod—Dizziness—Docetaxel—stomach cancer	0.000314	0.00137	CcSEcCtD
Fingolimod—Hypertension—Doxorubicin—stomach cancer	0.000314	0.00137	CcSEcCtD
Fingolimod—Skin disorder—Epirubicin—stomach cancer	0.000312	0.00136	CcSEcCtD
Fingolimod—Paraesthesia—Methotrexate—stomach cancer	0.000308	0.00134	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000307	0.00134	CcSEcCtD
Fingolimod—Dyspnoea—Methotrexate—stomach cancer	0.000306	0.00133	CcSEcCtD
Fingolimod—Dizziness—Capecitabine—stomach cancer	0.000304	0.00133	CcSEcCtD
Fingolimod—Hypotension—Epirubicin—stomach cancer	0.0003	0.00131	CcSEcCtD
Fingolimod—Headache—Docetaxel—stomach cancer	0.000298	0.0013	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000296	0.00129	CcSEcCtD
Fingolimod—Fatigue—Methotrexate—stomach cancer	0.000296	0.00129	CcSEcCtD
Fingolimod—Infection—Doxorubicin—stomach cancer	0.000295	0.00129	CcSEcCtD
Fingolimod—Nervous system disorder—Doxorubicin—stomach cancer	0.000291	0.00127	CcSEcCtD
Fingolimod—Headache—Capecitabine—stomach cancer	0.000288	0.00126	CcSEcCtD
Fingolimod—Skin disorder—Doxorubicin—stomach cancer	0.000288	0.00126	CcSEcCtD
Fingolimod—Paraesthesia—Epirubicin—stomach cancer	0.000288	0.00126	CcSEcCtD
Fingolimod—Dyspnoea—Epirubicin—stomach cancer	0.000286	0.00125	CcSEcCtD
Fingolimod—Hypotension—Doxorubicin—stomach cancer	0.000277	0.00121	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000277	0.00121	CcSEcCtD
Fingolimod—Fatigue—Epirubicin—stomach cancer	0.000277	0.00121	CcSEcCtD
Fingolimod—Paraesthesia—Doxorubicin—stomach cancer	0.000266	0.00116	CcSEcCtD
Fingolimod—Dyspnoea—Doxorubicin—stomach cancer	0.000265	0.00115	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000256	0.00112	CcSEcCtD
Fingolimod—Fatigue—Doxorubicin—stomach cancer	0.000256	0.00112	CcSEcCtD
Fingolimod—Asthenia—Methotrexate—stomach cancer	0.000246	0.00107	CcSEcCtD
Fingolimod—Pruritus—Methotrexate—stomach cancer	0.000242	0.00106	CcSEcCtD
Fingolimod—Diarrhoea—Methotrexate—stomach cancer	0.000235	0.00102	CcSEcCtD
Fingolimod—Asthenia—Epirubicin—stomach cancer	0.00023	0.001	CcSEcCtD
Fingolimod—Pruritus—Epirubicin—stomach cancer	0.000227	0.00099	CcSEcCtD
Fingolimod—Dizziness—Methotrexate—stomach cancer	0.000227	0.000989	CcSEcCtD
Fingolimod—Diarrhoea—Epirubicin—stomach cancer	0.000219	0.000958	CcSEcCtD
Fingolimod—Headache—Methotrexate—stomach cancer	0.000215	0.000937	CcSEcCtD
Fingolimod—Asthenia—Doxorubicin—stomach cancer	0.000213	0.000929	CcSEcCtD
Fingolimod—Dizziness—Epirubicin—stomach cancer	0.000212	0.000926	CcSEcCtD
Fingolimod—Pruritus—Doxorubicin—stomach cancer	0.00021	0.000916	CcSEcCtD
Fingolimod—Diarrhoea—Doxorubicin—stomach cancer	0.000203	0.000886	CcSEcCtD
Fingolimod—Headache—Epirubicin—stomach cancer	0.000201	0.000877	CcSEcCtD
Fingolimod—Dizziness—Doxorubicin—stomach cancer	0.000196	0.000856	CcSEcCtD
Fingolimod—Headache—Doxorubicin—stomach cancer	0.000186	0.000811	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—CXCL8—stomach cancer	5.48e-05	0.000121	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RHOA—stomach cancer	5.46e-05	0.00012	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—HRAS—stomach cancer	5.44e-05	0.00012	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NOS3—stomach cancer	5.4e-05	0.000119	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPAP2A—stomach cancer	5.37e-05	0.000118	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CDKN1B—stomach cancer	5.35e-05	0.000118	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL6R—stomach cancer	5.35e-05	0.000118	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CXCL8—stomach cancer	5.28e-05	0.000116	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCL8—stomach cancer	5.28e-05	0.000116	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GMPR2—stomach cancer	5.27e-05	0.000116	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—HRAS—stomach cancer	5.24e-05	0.000115	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—HRAS—stomach cancer	5.24e-05	0.000115	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTGS2—stomach cancer	5.23e-05	0.000115	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL6—stomach cancer	5.21e-05	0.000115	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CDKN1B—stomach cancer	5.15e-05	0.000113	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CDKN1B—stomach cancer	5.15e-05	0.000113	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—PIK3CA—stomach cancer	5.14e-05	0.000113	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCND1—stomach cancer	5.11e-05	0.000112	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—JUN—stomach cancer	5.09e-05	0.000112	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ERBB2—stomach cancer	5.05e-05	0.000111	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL6—stomach cancer	5.02e-05	0.00011	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL6—stomach cancer	5.02e-05	0.00011	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SERPINE1—stomach cancer	5.01e-05	0.00011	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MMP9—stomach cancer	4.96e-05	0.000109	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CDKN1A—stomach cancer	4.94e-05	0.000109	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCND1—stomach cancer	4.91e-05	0.000108	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCND1—stomach cancer	4.91e-05	0.000108	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—JUN—stomach cancer	4.9e-05	0.000108	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—JUN—stomach cancer	4.9e-05	0.000108	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RHOA—stomach cancer	4.83e-05	0.000106	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MAPK8—stomach cancer	4.82e-05	0.000106	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—IDH3B—stomach cancer	4.82e-05	0.000106	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SUCLG1—stomach cancer	4.82e-05	0.000106	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CXCL8—stomach cancer	4.79e-05	0.000105	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—FBP1—stomach cancer	4.78e-05	0.000105	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CA1—stomach cancer	4.78e-05	0.000105	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NDUFA2—stomach cancer	4.78e-05	0.000105	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CKB—stomach cancer	4.78e-05	0.000105	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NOS3—stomach cancer	4.78e-05	0.000105	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MMP9—stomach cancer	4.77e-05	0.000105	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MMP9—stomach cancer	4.77e-05	0.000105	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—HRAS—stomach cancer	4.76e-05	0.000105	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CDKN1A—stomach cancer	4.75e-05	0.000105	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CDKN1A—stomach cancer	4.75e-05	0.000105	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CDKN1B—stomach cancer	4.68e-05	0.000103	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MAPK8—stomach cancer	4.64e-05	0.000102	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MAPK8—stomach cancer	4.64e-05	0.000102	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL6—stomach cancer	4.55e-05	0.0001	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PLIN2—stomach cancer	4.5e-05	9.9e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTP1—stomach cancer	4.49e-05	9.89e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NDUFS1—stomach cancer	4.48e-05	9.86e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NDUFV1—stomach cancer	4.48e-05	9.86e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ERBB2—stomach cancer	4.47e-05	9.84e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCND1—stomach cancer	4.46e-05	9.82e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—JUN—stomach cancer	4.45e-05	9.8e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VEGFA—stomach cancer	4.45e-05	9.8e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	4.43e-05	9.76e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—STAT3—stomach cancer	4.41e-05	9.7e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CA2—stomach cancer	4.37e-05	9.63e-05	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PIK3CA—stomach cancer	4.34e-05	9.54e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MMP9—stomach cancer	4.33e-05	9.54e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CDKN1A—stomach cancer	4.32e-05	9.5e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—VEGFA—stomach cancer	4.28e-05	9.43e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VEGFA—stomach cancer	4.28e-05	9.43e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PGAM1—stomach cancer	4.26e-05	9.38e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NT5E—stomach cancer	4.26e-05	9.38e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—STAT3—stomach cancer	4.24e-05	9.34e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—STAT3—stomach cancer	4.24e-05	9.34e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCL8—stomach cancer	4.24e-05	9.33e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MAPK8—stomach cancer	4.21e-05	9.27e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MAPK3—stomach cancer	4.21e-05	9.27e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CDKN1B—stomach cancer	4.14e-05	9.11e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTM1—stomach cancer	4.13e-05	9.09e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MYC—stomach cancer	4.1e-05	9.01e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	4.07e-05	8.96e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PLCE1—stomach cancer	4.07e-05	8.95e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALDH7A1—stomach cancer	4.07e-05	8.95e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MAPK3—stomach cancer	4.05e-05	8.92e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MAPK3—stomach cancer	4.05e-05	8.92e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MAPK1—stomach cancer	4.01e-05	8.82e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EGFR—stomach cancer	4.01e-05	8.82e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PGLS—stomach cancer	3.99e-05	8.79e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—BLVRB—stomach cancer	3.99e-05	8.79e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCND1—stomach cancer	3.95e-05	8.69e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MYC—stomach cancer	3.94e-05	8.68e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MYC—stomach cancer	3.94e-05	8.68e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—JUN—stomach cancer	3.94e-05	8.67e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—UMPS—stomach cancer	3.9e-05	8.58e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VEGFA—stomach cancer	3.89e-05	8.56e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ACAD8—stomach cancer	3.86e-05	8.5e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MAPK1—stomach cancer	3.86e-05	8.49e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MAPK1—stomach cancer	3.86e-05	8.49e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EGFR—stomach cancer	3.86e-05	8.49e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EGFR—stomach cancer	3.86e-05	8.49e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—STAT3—stomach cancer	3.85e-05	8.48e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MMP9—stomach cancer	3.83e-05	8.44e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CDKN1A—stomach cancer	3.82e-05	8.41e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPAP2A—stomach cancer	3.81e-05	8.38e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—KRAS—stomach cancer	3.78e-05	8.33e-05	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PIK3CA—stomach cancer	3.74e-05	8.24e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MAPK8—stomach cancer	3.73e-05	8.21e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MAPK3—stomach cancer	3.68e-05	8.1e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—KRAS—stomach cancer	3.64e-05	8.02e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KRAS—stomach cancer	3.64e-05	8.02e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PDHA1—stomach cancer	3.62e-05	7.98e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ECHS1—stomach cancer	3.62e-05	7.98e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MYC—stomach cancer	3.58e-05	7.88e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MAPK1—stomach cancer	3.5e-05	7.71e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EGFR—stomach cancer	3.5e-05	7.71e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PIK3CA—stomach cancer	3.48e-05	7.65e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GMPR2—stomach cancer	3.44e-05	7.58e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VEGFA—stomach cancer	3.44e-05	7.58e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—STAT3—stomach cancer	3.41e-05	7.5e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TYMP—stomach cancer	3.41e-05	7.5e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—FADS1—stomach cancer	3.41e-05	7.5e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CKB—stomach cancer	3.39e-05	7.47e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CA1—stomach cancer	3.39e-05	7.47e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NDUFA2—stomach cancer	3.39e-05	7.47e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—FBP1—stomach cancer	3.39e-05	7.47e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—stomach cancer	3.36e-05	7.4e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PIK3CA—stomach cancer	3.35e-05	7.37e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PIK3CA—stomach cancer	3.35e-05	7.37e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KRAS—stomach cancer	3.31e-05	7.28e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MAPK3—stomach cancer	3.26e-05	7.17e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—stomach cancer	3.24e-05	7.13e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—stomach cancer	3.24e-05	7.13e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HRAS—stomach cancer	3.22e-05	7.08e-05	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PIK3CA—stomach cancer	3.22e-05	7.08e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SREBF2—stomach cancer	3.19e-05	7.02e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PLIN2—stomach cancer	3.19e-05	7.02e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MYC—stomach cancer	3.17e-05	6.97e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—RORA—stomach cancer	3.15e-05	6.94e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—IDH3B—stomach cancer	3.15e-05	6.93e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SUCLG1—stomach cancer	3.15e-05	6.93e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CA2—stomach cancer	3.1e-05	6.83e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MAPK1—stomach cancer	3.1e-05	6.82e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EGFR—stomach cancer	3.1e-05	6.82e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HRAS—stomach cancer	3.1e-05	6.81e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HRAS—stomach cancer	3.1e-05	6.81e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL6—stomach cancer	3.08e-05	6.78e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CA—stomach cancer	3.04e-05	6.69e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NT5E—stomach cancer	3.03e-05	6.66e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PGAM1—stomach cancer	3.03e-05	6.66e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL6—stomach cancer	2.96e-05	6.52e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL6—stomach cancer	2.96e-05	6.52e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALDOB—stomach cancer	2.95e-05	6.5e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—stomach cancer	2.94e-05	6.47e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NDUFV1—stomach cancer	2.93e-05	6.44e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NDUFS1—stomach cancer	2.93e-05	6.44e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KRAS—stomach cancer	2.93e-05	6.44e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALDH7A1—stomach cancer	2.89e-05	6.35e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PLCE1—stomach cancer	2.89e-05	6.35e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HRAS—stomach cancer	2.81e-05	6.19e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—UMPS—stomach cancer	2.77e-05	6.09e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALOX5—stomach cancer	2.75e-05	6.05e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—DPYD—stomach cancer	2.7e-05	5.95e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL6—stomach cancer	2.69e-05	5.92e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CA—stomach cancer	2.69e-05	5.92e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PGLS—stomach cancer	2.61e-05	5.74e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—BLVRB—stomach cancer	2.61e-05	5.74e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—stomach cancer	2.6e-05	5.73e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ECHS1—stomach cancer	2.57e-05	5.66e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PDHA1—stomach cancer	2.57e-05	5.66e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPAP2A—stomach cancer	2.49e-05	5.48e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HRAS—stomach cancer	2.49e-05	5.48e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TYMP—stomach cancer	2.42e-05	5.32e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—FADS1—stomach cancer	2.42e-05	5.32e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTT1—stomach cancer	2.39e-05	5.26e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL6—stomach cancer	2.38e-05	5.24e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP2A6—stomach cancer	2.36e-05	5.2e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AKR1C3—stomach cancer	2.3e-05	5.06e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SREBF2—stomach cancer	2.26e-05	4.98e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ENO1—stomach cancer	2.24e-05	4.93e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—RORA—stomach cancer	2.24e-05	4.93e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—FBP1—stomach cancer	2.22e-05	4.88e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NDUFA2—stomach cancer	2.22e-05	4.88e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CA1—stomach cancer	2.22e-05	4.88e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CKB—stomach cancer	2.22e-05	4.88e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALDOB—stomach cancer	2.1e-05	4.62e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PLIN2—stomach cancer	2.09e-05	4.59e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CA2—stomach cancer	2.03e-05	4.47e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CD44—stomach cancer	1.99e-05	4.37e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PGAM1—stomach cancer	1.98e-05	4.35e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NT5E—stomach cancer	1.98e-05	4.35e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALOX5—stomach cancer	1.95e-05	4.29e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—DPYD—stomach cancer	1.92e-05	4.22e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.89e-05	4.15e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PLCE1—stomach cancer	1.89e-05	4.15e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—UMPS—stomach cancer	1.81e-05	3.98e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTT1—stomach cancer	1.7e-05	3.73e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPP2R1A—stomach cancer	1.69e-05	3.72e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ECHS1—stomach cancer	1.68e-05	3.7e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PDHA1—stomach cancer	1.68e-05	3.7e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP2A6—stomach cancer	1.68e-05	3.69e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTP1—stomach cancer	1.66e-05	3.65e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HMOX1—stomach cancer	1.63e-05	3.6e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AKR1C3—stomach cancer	1.63e-05	3.59e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ENO1—stomach cancer	1.59e-05	3.5e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TYMP—stomach cancer	1.58e-05	3.48e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—FADS1—stomach cancer	1.58e-05	3.48e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TYMS—stomach cancer	1.54e-05	3.39e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTM1—stomach cancer	1.52e-05	3.35e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SREBF2—stomach cancer	1.48e-05	3.26e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—RORA—stomach cancer	1.46e-05	3.22e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ERCC2—stomach cancer	1.43e-05	3.15e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CD44—stomach cancer	1.41e-05	3.1e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALDOB—stomach cancer	1.37e-05	3.02e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MTHFR—stomach cancer	1.35e-05	2.96e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALOX5—stomach cancer	1.27e-05	2.81e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—DPYD—stomach cancer	1.25e-05	2.76e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CAV1—stomach cancer	1.24e-05	2.73e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—APOA1—stomach cancer	1.24e-05	2.73e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPP2R1A—stomach cancer	1.2e-05	2.64e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTP1—stomach cancer	1.18e-05	2.59e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HMOX1—stomach cancer	1.16e-05	2.55e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTT1—stomach cancer	1.11e-05	2.44e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.1e-05	2.41e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TYMS—stomach cancer	1.09e-05	2.41e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPARG—stomach cancer	1.09e-05	2.4e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTM1—stomach cancer	1.08e-05	2.38e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.07e-05	2.35e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ENO1—stomach cancer	1.04e-05	2.29e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ERCC2—stomach cancer	1.02e-05	2.24e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALB—stomach cancer	9.81e-06	2.16e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MTHFR—stomach cancer	9.55e-06	2.1e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NOS3—stomach cancer	9.38e-06	2.07e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CD44—stomach cancer	9.21e-06	2.03e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CAV1—stomach cancer	8.81e-06	1.94e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—APOA1—stomach cancer	8.79e-06	1.93e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—stomach cancer	8.58e-06	1.89e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPP2R1A—stomach cancer	7.83e-06	1.72e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPARG—stomach cancer	7.74e-06	1.7e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTP1—stomach cancer	7.69e-06	1.69e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HMOX1—stomach cancer	7.58e-06	1.67e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TYMS—stomach cancer	7.14e-06	1.57e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTM1—stomach cancer	7.06e-06	1.55e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALB—stomach cancer	6.96e-06	1.53e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NOS3—stomach cancer	6.66e-06	1.47e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ERCC2—stomach cancer	6.64e-06	1.46e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MTHFR—stomach cancer	6.24e-06	1.37e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—stomach cancer	6.09e-06	1.34e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CAV1—stomach cancer	5.76e-06	1.27e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APOA1—stomach cancer	5.74e-06	1.26e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CA—stomach cancer	5.28e-06	1.16e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPARG—stomach cancer	5.06e-06	1.11e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALB—stomach cancer	4.55e-06	1e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NOS3—stomach cancer	4.35e-06	9.58e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—stomach cancer	3.98e-06	8.76e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CA—stomach cancer	3.75e-06	8.25e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CA—stomach cancer	2.45e-06	5.39e-06	CbGpPWpGaD
